Avelox Clinical Trials Avelox RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Thorough QT Study to Evaluate the Effect of Rodatristat Ethyl, Rodatristat and Its Major Metabolites on the Heart
Condition:   Healthy Interventions:   Drug: Rodatristat Ethyl;   Drug: Moxifloxacin;   Drug: Placebo for Rodatristat;   Drug: Placebo for Moxifloxacin Sponsors:   Altavant Sciences GmbH;   Altasciences Clinical Kansas, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials

A TQTc Study for Omaveloxolone
Condition:   Health Adult Subjects Interventions:   Drug: Omaveloxolone;   Drug: Moxifloxacin Sponsors:   Reata Pharmaceuticals, Inc.;   Celerion;   Q2 Solutions Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2023 Category: Research Source Type: clinical trials

BTZ-043 Dose Evaluation in Combination and Selection
Conditions:   Tuberculosis, Pulmonary;   Other Specified Pulmonary Tuberculosis Interventions:   Drug: BTZ-043;   Drug: Bedaquiline;   Drug: Delamanid;   Drug: Moxifloxacin Sponsors:   Michael Hoelscher;   Radboud University Medical Center;   University of California, San Francisco;   University College, London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2023 Category: Research Source Type: clinical trials

A TQTc Study for Omaveloxolone
Condition:   Health Adult Subjects Interventions:   Drug: Omaveloxolone;   Drug: Moxifloxacin Sponsors:   Reata Pharmaceuticals, Inc.;   Celerion;   Q2 Solutions Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2023 Category: Research Source Type: clinical trials

BTZ-043 Dose Evaluation in Combination and Selection
Conditions:   Tuberculosis, Pulmonary;   Other Specified Pulmonary Tuberculosis Interventions:   Drug: BTZ-043;   Drug: Bedaquiline;   Drug: Delamanid;   Drug: Moxifloxacin Sponsors:   Michael Hoelscher;   Radboud University Medical Center;   University of California, San Francisco;   University College, London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2023 Category: Research Source Type: clinical trials

A TQTc Study for Omaveloxolone
Condition:   Health Adult Subjects Interventions:   Drug: Omaveloxolone;   Drug: Moxifloxacin Sponsors:   Reata Pharmaceuticals, Inc.;   Celerion;   Q2 Solutions Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2023 Category: Research Source Type: clinical trials